基因毒性检测市场规模、份额和成长分析（按检测方法、产品、检测类型、最终用户和地区）- 产业预测 2025-2032

2023 年基因毒性测试市场规模价值 15.8 亿美元，预计将从 2024 年的 17.7 亿美元成长到 2032 年的 43.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.8%。

遗传毒性测试市场在製药、生物技术和化学领域变得越来越重要，以确保对新药、化学物质和消费品进行全面的安全评估。由于监管要求的不断提高、测试方法的进步以及社会对健康和安全的日益关注，该市场正在经历显着的增长。主要成长动力包括药品和化学品研发活动的活性化、全球卫生当局的严格监管以及对与遗传毒性物质相关的长期风险的认识不断提高。虽然 Ames 试验等传统方法仍然很重要，但它们正透过体外微核试验和高通量筛检等创新技术而增强。这种向非动物测试模式的演变符合道德标准，推动了市场成长并拓宽了专门从事该领域的主要企业和受託研究机构的服务范围。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

基因毒性测试市场规模（按测试方法和复合年增长率） (2025-2032)

• 市场概况
• 体外测试
• 体内测试
• 计算毒理学
• 高通量筛检

基因毒性测试市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 试剂和耗材
• 检测试剂套件
• 服务

基因毒性检测市场规模（依检测类型和复合年增长率） (2025-2032)

• 市场概况
• 艾姆斯试验
• 微核试验
• 彗星试验
• 染色体异常检测

基因毒性测试市场规模（按最终用户和复合年增长率划分）（2025-2032）

• 市场概况
• 製药公司
• 研究组织
• 合约研究组织 (CRO)
• 政府

基因毒性测试市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（USA）
• Charles River Laboratories International, Inc.（USA）
• Laboratory Corp of America Holdings（USA）
• Eurofins Scientific（Germany）
• Jubilant Life Sciences Limited（India）
• Merck KGaA（Germany）
• Toxikon Corporation（USA）
• Gentronix Limited（UK）
• WuXi AppTec（China）
• Inotiv Inc.（USA）
• Creative Bioarray（USA）
• MB Research Laboratories（USA）
• Molecular Toxicology Inc.（USA）
• Toxys（Netherlands）
• Syngene International Limited（India）
• GeneTox Worldwide Inc.（USA）
• Scantox Group（Denmark）
• Covance Inc.（USA）
• BioReliance Corporation（USA）
• Envigo（USA）

结论和建议

Genetic Toxicology Testing Market size was valued at USD 1.58 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 4.31 billion by 2032, growing at a CAGR of 11.8% during the forecast period (2025-2032).

The genetic toxicology testing market is increasingly pivotal in the pharmaceutical, biotechnology, and chemical sectors, ensuring comprehensive safety assessments of new drugs, chemicals, and consumer products. With rising regulatory demands, advancements in testing methodologies, and a growing public focus on health and safety, this market is witnessing significant expansion. Key growth drivers include intensified research and development activities in pharmaceuticals and chemicals, strict regulations from global health authorities, and rising awareness of the long-term risks associated with genotoxic substances. While traditional methods like the Ames test remain vital, they are being enhanced by innovative techniques such as in vitro micronucleus assays and high-throughput screening. This evolution towards non-animal testing models is in line with ethical standards, facilitating market growth and broadening the service offerings of key players and contract research organizations specializing in this field.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genetic Toxicology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genetic Toxicology Testing Market Segments Analysis

Global Genetic Toxicology Testing Market is segmented by Testing Methodology, Product, Assay Type, End User and region. Based on Testing Methodology, the market is segmented into In Vitro Testing, In Vivo Testing, Computational Toxicology and High-Throughput Screening. Based on Product, the market is segmented into Reagents & Consumables, Assay Kits and Services. Based on Assay Type, the market is segmented into Ames Test, Micronucleus Test, Comet Assay and Chromosomal Aberration Test. Based on End User, the market is segmented into Pharmaceutical Companies, Research Institutions, Contract Research Organizations (CROs) and Government Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genetic Toxicology Testing Market

A key factor propelling the growth of the Genetic Toxicology Testing market is the increasing awareness among both individuals and healthcare professionals regarding the significance of genetic health and its implications. This heightened understanding underscores the importance of genetic toxicology testing, which plays a crucial role in identifying potential risks linked to environmental exposures, including chemicals, pharmaceuticals, and pollutants. By providing insights into these risks, genetic toxicology testing facilitates personalized healthcare approaches and promotes preventive strategies, ultimately contributing to better health outcomes and enhancing public awareness of genetic considerations in health management.

Restraints in the Genetic Toxicology Testing Market

The Genetic Toxicology Testing market faces significant restraints due to ethical concerns associated with the analysis of genetic information. Issues surrounding privacy, informed consent, and the potential for misuse of personal data present major challenges. The meticulous collection, storage, and application of genetic data necessitate compliance with stringent privacy regulations, which can serve as a barrier to the broad acceptance and implementation of this testing in various sectors. Consequently, these ethical and regulatory dilemmas may impede the growth of the market, limiting its potential benefits and prompting cautious engagement from both providers and consumers.

Market Trends of the Genetic Toxicology Testing Market

The genetic toxicology testing market is experiencing a pronounced trend towards in vitro testing methods, reflecting a broader shift in regulatory and scientific practices. Traditional animal models are progressively being supplanted by cell-based assays that not only alleviate ethical concerns but also enhance the speed and cost-efficiency of testing processes. Prominent in this transition are in vitro techniques such as the Ames test, micronucleus assay, and Comet assay, which demonstrate a strong correlation with human biology and offer reliable assessments of genotoxicity and mutagenicity. This trend is further reinforced by the endorsement from regulatory agencies advocating for more humane and efficient testing methodologies, propelling the accelerated adoption of these innovative approaches across the industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Genetic Toxicology Testing Market Size by Testing Methodology & CAGR (2025-2032)

• Market Overview
• In Vitro Testing
• In Vivo Testing
• Computational Toxicology
• High-Throughput Screening

Global Genetic Toxicology Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Reagents & Consumables
• Assay Kits
• Services

Global Genetic Toxicology Testing Market Size by Assay Type & CAGR (2025-2032)

• Market Overview
• Ames Test
• Micronucleus Test
• Comet Assay
• Chromosomal Aberration Test

Global Genetic Toxicology Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Research Institutions
• Contract Research Organizations (CROs)
• Government Agencies

Global Genetic Toxicology Testing Market Size & CAGR (2025-2032)

• North America (Testing Methodology, Product, Assay Type, End User)
  • US
  • Canada
• Europe (Testing Methodology, Product, Assay Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Testing Methodology, Product, Assay Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Testing Methodology, Product, Assay Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Testing Methodology, Product, Assay Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corp of America Holdings (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Life Sciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toxikon Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gentronix Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotiv Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MB Research Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Toxicology Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toxys (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneTox Worldwide Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scantox Group (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioReliance Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envigo (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations